Skip to main content

Baxter International company profile

  • BAX · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$25.81+0.27%Close 13 Nov 2026 · Market value $13.30B

About Baxter International

Baxter International Inc. provides healthcare products through its subsidiaries, including sterile intravenous solutions, infusion systems, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. Its products are used by hospitals, nursing homes, ambulatory surgery centers, doctors' offices, kidney dialysis centers and patients at home under physician supervision. Baxter reports three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. Sales are made directly and through independent distributors, sales agents and specialty pharmacies in more than 100 countries, and products are manufactured in over 20 countries.

A summary of the business section of the company's latest annual report, filed 12 Feb 2026.

Company facts

TickerBAX · NYSE
SectorMedical devices
IndustryHealth Care Equipment
IndexS&P 500
Fiscal year ends31 December
Reporting currencyUSD
CIK10456
Latest annual report10-K, filed 12 Feb 2026

Officers and directors

NameRoleShares ownedLatest Form 4
Hider Andrew P.President and CEO · Director—Shares withheld for tax, 2 Sep 2026
Foster JuliePresident, Front Line Care—Shares withheld for tax, 2 Sep 2026
Teaff JamesPresident, CCS—Shares withheld for tax, 1 Sep 2026
Wallace Steven P.President, Adv. Surgery—Shares withheld for tax, 2 Jun 2026
Zielinski Anita ASVP, Interim CFO, CAO & Cntrlr—Grant or award, 1 Jun 2026
Wilkes David S.Director—Grant or award, 5 May 2026
Wendell Amy McBrideDirector—Grant or award, 5 May 2026
SCHLICHTING NANCY MDirector—Grant or award, 5 May 2026
MORRISON PATRICIADirector—Grant or award, 5 May 2026
Shafer David BrentDirector · Chair of the Board—Grant or award, 5 May 2026
McDonnell Michael R.Director—Grant or award, 5 May 2026
Craig Jeffrey ADirector—Grant or award, 5 May 2026
Ampofo William A. IIDirector—Grant or award, 5 May 2026
Soriano Maria CeciliaGroup Pres., ITT & Pharma.—Shares withheld for tax, 6 Mar 2026
Rosenbloom David S.EVP and General Counsel—Shares withheld for tax, 6 Mar 2026
Rasul ReazurEVP,Group Pres,Healthcare—Shares withheld for tax, 6 Mar 2026
Grade Joel T.EVP and CFO—Shares withheld for tax, 6 Mar 2026
Carlisle CynthiaExecutive Vice President, CHRO—Grant or award, 27 Feb 2026
Mason Jeanne KEVP, Chief HR Officer—Shares withheld for tax, 12 Dec 2025
Sonig AlokEVP,Group President,Pharma—Shares withheld for tax, 2 Sep 2025

Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.

BAX in the terminal

The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.